455 related articles for article (PubMed ID: 25769830)
1. Pseudomycoicidin, a Class II Lantibiotic from Bacillus pseudomycoides.
Basi-Chipalu S; Dischinger J; Josten M; Szekat C; Zweynert A; Sahl HG; Bierbaum G
Appl Environ Microbiol; 2015 May; 81(10):3419-29. PubMed ID: 25769830
[TBL] [Abstract][Full Text] [Related]
2. Production of the novel two-peptide lantibiotic lichenicidin by Bacillus licheniformis DSM 13.
Dischinger J; Josten M; Szekat C; Sahl HG; Bierbaum G
PLoS One; 2009 Aug; 4(8):e6788. PubMed ID: 19707558
[TBL] [Abstract][Full Text] [Related]
3. Formicin - a novel broad-spectrum two-component lantibiotic produced by Bacillus paralicheniformis APC 1576.
Collins FWJ; O'Connor PM; O'Sullivan O; Rea MC; Hill C; Ross RP
Microbiology (Reading); 2016 Sep; 162(9):1662-1671. PubMed ID: 27450592
[TBL] [Abstract][Full Text] [Related]
4. Posttranslationally modified bacteriocins--the lantibiotics.
Guder A; Wiedemann I; Sahl HG
Biopolymers; 2000; 55(1):62-73. PubMed ID: 10931442
[TBL] [Abstract][Full Text] [Related]
5. Characterization of amylolysin, a novel lantibiotic from Bacillus amyloliquefaciens GA1.
Arguelles Arias A; Ongena M; Devreese B; Terrak M; Joris B; Fickers P
PLoS One; 2013; 8(12):e83037. PubMed ID: 24349428
[TBL] [Abstract][Full Text] [Related]
6. Heterologous Expression of Mersacidin in
Viel JH; Jaarsma AH; Kuipers OP
ACS Synth Biol; 2021 Mar; 10(3):600-608. PubMed ID: 33689311
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel two-peptide lantibiotic, haloduracin, produced by the alkaliphile Bacillus halodurans C-125.
Lawton EM; Cotter PD; Hill C; Ross RP
FEMS Microbiol Lett; 2007 Feb; 267(1):64-71. PubMed ID: 17233677
[TBL] [Abstract][Full Text] [Related]
8. The biology of lantibiotics from the lacticin 481 group is coming of age.
Dufour A; Hindré T; Haras D; Le Pennec JP
FEMS Microbiol Rev; 2007 Mar; 31(2):134-67. PubMed ID: 17096664
[TBL] [Abstract][Full Text] [Related]
9. The lantibiotic mersacidin is an autoinducing peptide.
Schmitz S; Hoffmann A; Szekat C; Rudd B; Bierbaum G
Appl Environ Microbiol; 2006 Nov; 72(11):7270-7. PubMed ID: 16980420
[TBL] [Abstract][Full Text] [Related]
10. Discovery and in vitro biosynthesis of haloduracin, a two-component lantibiotic.
McClerren AL; Cooper LE; Quan C; Thomas PM; Kelleher NL; van der Donk WA
Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17243-8. PubMed ID: 17085596
[TBL] [Abstract][Full Text] [Related]
11. Characterization of new class III lantibiotics--erythreapeptin, avermipeptin and griseopeptin from Saccharopolyspora erythraea, Streptomyces avermitilis and Streptomyces griseus demonstrates stepwise N-terminal leader processing.
Völler GH; Krawczyk JM; Pesic A; Krawczyk B; Nachtigall J; Süssmuth RD
Chembiochem; 2012 May; 13(8):1174-83. PubMed ID: 22556031
[TBL] [Abstract][Full Text] [Related]
12. Elucidation of the Bridging Pattern of the Lantibiotic Pseudomycoicidin.
Janssen K; Krasenbrink J; Strangfeld S; Kroheck S; Josten M; Engeser M; Bierbaum G
Chembiochem; 2023 Jan; 24(2):e202200540. PubMed ID: 36399337
[TBL] [Abstract][Full Text] [Related]
13. Expression of the lantibiotic mersacidin in Bacillus amyloliquefaciens FZB42.
Herzner AM; Dischinger J; Szekat C; Josten M; Schmitz S; Yakéléba A; Reinartz R; Jansen A; Sahl HG; Piel J; Bierbaum G
PLoS One; 2011; 6(7):e22389. PubMed ID: 21811596
[TBL] [Abstract][Full Text] [Related]
14. Modifying the Lantibiotic Mutacin 1140 for Increased Yield, Activity, and Stability.
Geng M; Smith L
Appl Environ Microbiol; 2018 Aug; 84(15):. PubMed ID: 29776930
[TBL] [Abstract][Full Text] [Related]
15. Heterologous expression, biosynthesis, and mutagenesis of type II lantibiotics from Bacillus licheniformis in Escherichia coli.
Caetano T; Krawczyk JM; Mösker E; Süssmuth RD; Mendo S
Chem Biol; 2011 Jan; 18(1):90-100. PubMed ID: 21276942
[TBL] [Abstract][Full Text] [Related]
16. Congeneric lantibiotics from ribosomal in vivo peptide synthesis with noncanonical amino acids.
Oldach F; Al Toma R; Kuthning A; Caetano T; Mendo S; Budisa N; Süssmuth RD
Angew Chem Int Ed Engl; 2012 Jan; 51(2):415-8. PubMed ID: 22128014
[TBL] [Abstract][Full Text] [Related]
17. Amylocyclicin, a novel circular bacteriocin produced by Bacillus amyloliquefaciens FZB42.
Scholz R; Vater J; Budiharjo A; Wang Z; He Y; Dietel K; Schwecke T; Herfort S; Lasch P; Borriss R
J Bacteriol; 2014 May; 196(10):1842-52. PubMed ID: 24610713
[TBL] [Abstract][Full Text] [Related]
18. Lantibiotic engineering: molecular characterization and exploitation of lantibiotic-synthesizing enzymes for peptide engineering.
Nagao J; Aso Y; Shioya K; Nakayama J; Sonomoto K
J Mol Microbiol Biotechnol; 2007; 13(4):235-42. PubMed ID: 17827974
[TBL] [Abstract][Full Text] [Related]
19. Deuterium labeled peptides give insights into the directionality of class III lantibiotic synthetase LabKC.
Krawczyk B; Ensle P; Müller WM; Süssmuth RD
J Am Chem Soc; 2012 Jun; 134(24):9922-5. PubMed ID: 22687055
[TBL] [Abstract][Full Text] [Related]
20. Isolation, structure elucidation, and synergistic antibacterial activity of a novel two-component lantibiotic lichenicidin from Bacillus licheniformis VK21.
Shenkarev ZO; Finkina EI; Nurmukhamedova EK; Balandin SV; Mineev KS; Nadezhdin KD; Yakimenko ZA; Tagaev AA; Temirov YV; Arseniev AS; Ovchinnikova TV
Biochemistry; 2010 Aug; 49(30):6462-72. PubMed ID: 20578714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
